This course will review cancer pathophysiology; its treatment and impact on body systems and functions; balance; fall risk; and chemotherapy-induced peripheral neuropathy in cancer survivors. Based on the analyses of the population-based data from the Surveillance, Epidemiology and End Results (SEER) and Medicare Health Outcomes Survey (MHOS), the speakers will introduce a prospective surveillance model to improve outcomes of balance and fall risks in older cancer survivors. Participants will be able to use the data gathered from the history, review of systems, systems review, examination, and evaluation to identify cancer survivors who are at risk of balance disorders, falls, or chemotherapy-induced peripheral neuropathy. The speakers will emphasize the use of evidence based screening tools and outcomes measures, and use lab case studies to address evidence-based application of interventions.

Meet our Speakers

Lucinda A. Pfalzer, PT, PhD, FACSM, FAPTA received a bachelor's degree in physical therapy (PT) from Ithaca College in 1979, a master's in Adult Fitness and Cardiac Rehabilitation in 1984 and a PhD in Exercise Physiology in 1989, both from The Ohio State University. Dr. Pfalzer joined University of Michigan (UM)-Flint as an Assistant Professor in June of 1986. She was promoted to Associate professor in 1992, Full Professor in 1998, and Professor Emerita in 2014. She was named a Catherine Worthingham Fellow of the APTA in 2007.

Genevieve Colon, PT, DPT is a practicing physical therapist and adjunct professor at Mid-Michigan Community College in Mount Pleasant, MI. She received a Bachelor of Science in Biology/Chemistry as well as her Doctorate in Physical Therapy from the University of Michigan – Flint. She has served on the APTA Oncology Sections’ Breast Cancer EDGE Task Force of Outcome Measures on Balance in 2014-2015, as well as many other EDGE Task Force initiatives through the Oncology Section of the APTA. She has presented her research along with her fellow authors at multiple national conferences to date and is published in peer-reviewed journals such as Rehabilitation Oncology.

Jennifer Blackwood PT, PhD is a Board Certified Geriatric Clinical Specialist through the American Board of Physical Therapy Specialties since 2008. She received her PhD in Interdisciplinary Health Sciences from Western Michigan University, Masters of Physical Therapy and Bachelors of Health Science from the University of Michigan and a Bachelor of Science in Biology from Bowling Green State University. Her research focuses on examining relationships between cognition deficits and physical mobility/fall risk in older adults.

Course Code:




cert_CA approval


cert_Insert Up To


cert_Logo One

cert_No IACET


cert_NY approval


cert_OH approval code


cert_OH hours


cert_OK category


cert_OK hours


cert_Transcript stmt


cert_TX approval


Completion Instructions

Review course content, complete the assessment with at least a 70% score, claim certificate, complete course evaluation.

Course level


Date published


Delivery method



Lucinda A. Pfalzer, PT, PhD, FACSM, FAPTA; Genevieve Colon, PT, DPT; Jennifer Blackwood PT, PhD

Learning objectives

At the conclusion of this course, the participant will be able to:

  1. Discuss the unique and diverse systemic and local effects of cancer and its treatment especially those that impact balance and increase risks of falls.
  2. Apply evidence-based screening tools and outcome measures within the ICF framework for the management of balance problems, fall risk, and chemotherapy-induced peripheral neuropathy in cancer survivors.
  3. Apply evidence-based treatment strategies while considering physical therapy diagnosis and prognosis to improve balance and reduce falls risk in cancer survivors.


Academy of Oncologic Physical Therapy

Brought to you by


1Oncology_BalanceFalls_2017 Oct.mp4
2Assessment - Balance and Falls in patients with cancer
Type:E-Learning Course
Credit Categories
Domains:Jennifer Blackwood, oncology, Cindy Pfalzer, Jena Colon, balance and falls
Available discounts:
  • Non Member
    (until 12/31/2030)
  • Member
    (until 12/31/2030)
  • Oncology
    (until 12/31/2030)
* Prices in US Dollar